Gastric Intrinsic Factor-Ardemann et al. BRITISH 603 duction. Finally, the secretion of intrinsic factor also precedes that of pepsin.
Company, Michigan, in 1961 (Mason, Dietz, and Deboer, 1962) . It is a monobasic compound and is obtained as the hydrochloride, in which form it is very readily soluble in water. The hydrochloride has the empirical formula C18 ,34N206S. HC1 .1H20 (molecular weight 452) (Herr and Bergy, 1962) . Early reports indicate that it has an activity, similar to that of erythromycin against Gram-positive cocci both in vitro and in experimental infections in mice (Lewis, Clapp, and Grady, 1962) , although the high solubility and low molecular weight suggest that it is not a macrolide.
Pristinamycin (pyostacine) was isolated in the RhonePoulenc Research Laboratories in the nineteen-fifties from a strain of Streptomyces pristinae spiralis. A series of laboratory and clinical studies were published together in Semaine Therapeutique (Benazet et al., 1962) . It is a mixture of two antibiotics, and recent studies have shown that there is a broad chemical similarity between pristinamycin and a number of other antibiotic mixtures-namely, staphylomycin (de Somer and van Dijck, 1955 ; Dijck, Vanderhaeghe, and de Somer, 1957) , ostreogrycin (E 129, Glaxo) (see Garrod and Waterworth, 1956) , streptogramin (Merck & Co.) (Verwey, West, and Miller, 1958) , synergistin (PA 144, Pfizer & Co.) (Celmer, 1955-6; Hobbs and Celmer, 1959) , and mikamycin (Arai, Fukahara, Nakamura, Yonehara, and Umezawa, 1958; Yamaguchi, 1961) . Partial cross-resistance with erythromycin has been recorded in the case of ostreogrycin (Garrod and Waterworth, 1956 ) and streptogramin (Jones, Nichols, and Finland, 1956 five strains showed the dissociated type of resistance described by Garrod (1957) ; that is to say, they were resistant to erythromycin but sensitive to other macrolides-for example, spiramycin. All these five were sensitive to lincomycin. None of the 12 strains was resistant to pristinamycin. lincomycin, as is the case with the macrolides, is progressively less active as the pH falls, and at pH 6 the activity is only oneeighth that in a neutral medium. Pristinamycin was unaffected by the pH within this range. Inoculum Size.-Six strains of Staph. aureus were tested for sensitivity to lincomycin with the standard inoculum-that is, a loopful of 1 in 500 dilution of an overnight broth culture -and also with a loopful of undiluted culture. In no case was there more than a twofold increase in the minimum inhibitory concentration with the larger inoculum.
Serum.-A strain of Staph. aureus was tested in broth and in 90 % human serum, in both cases with a diluted and undiluted inoculum. With lincomycin there was a twofold increase in the minimum inhibitory concentration in serum with the small inoculum and a fourfold increase with the large inoculum. With pristinamycin the respective increases were sixteenfold and thirty-twofold. Staph. aureus Erythromycin-sensitive Strains Passaged in Erythromycin.-Eight strains were passaged 25 times in the presence of erythromycin. As appears in Table IV , all the strains showed BRITISH MEDICAL JOURNAL a double increase in resistance to both erythromycin and spiramycin. With six strains the increase to erythromycin was 4,000-fold or more; three of these strains showed a 500-> 1,000-fold increase in resistance to lincomycin, and the other three showed a slight increase in resistance to this antibiotic. All eight strains showed a slight or moderate increase in resistance to pristinamycin, and the degree of resistance was greatest with the strains showing the least increase to the other antibiotics. Passage of strains of the dissociated-resistant type in erythromycin increased their resistance to this antibiotic but did not change the character of the resistance, so that in the absence of erythromycin they remained sensitive to spiramycin and also to linc6mycin. This is an important finding and will have to be taken into account in any attempt to explain how these two types of resistance to erythromycin arise naturally.
Development of Resistance to
The results here recorded with pristinamycin are in keeping with its chemical similarity to ostreogrvcin. As with the latter antibiotic (see Garrod and Waterworth, 1957) , there is some cross-resistance with the macrolides, but it is of a low order. Three of five strains habituated to pristinamycin showed a moderate increase in resistance to lincomycin, but the only strain rendered resistant to lincomycin by passage in that antibiotic remained fully sensitive to pristinamycin.
Summr
The antibacterial activity of lincomycin and pristinamycin has been studied and compared with that of erythromycin.
In spite of chemical differences, lincomycin has been shown to have an antibacterial activity similar to that of the macrolides, including partial cross-resistance.
Pristinamycin has an activity that might have been predicted from its chemical similarity to ostreogrycin.
